Finance Team National Hispanic Medical Association Leadership Fellowship 2003 Jose Castro MD Elsa Escalera MD Inginia Genao MD Advisor: Charles Brecher.

Slides:

Advertisements

Similar presentations

Dual Eligible and Low-Income Medicare Beneficiaries and Part D Presentation to National Medicaid Congress by Andy Schneider, Senior Advisor June 5, 2006.

Advertisements

K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Figure 0 The Transition of Dual Eligibles to Medicare Drug Coverage: Implications for Beneficiaries.

THE URBAN INSTITUTE Genevieve Kenney 2009 ACAP Medicaid Managed Care Policy Summit Hotel Monaco – Washington, DC July 15, 2009 Health Reform for Children:

K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Figure 0 Medicaid: The Basics Diane Rowland, Sc.D. Executive Director Kaiser Commission.

Challenges of Serving Low-income Medicare Beneficiaries: Impact of Cost Sharing Cindy Parks Thomas Brandeis University Schneider Institute for Health Policy.

Medicare & Medicaid. 2 Medicare – Medical Care for the Elderly l Institutional features – Part A—Hospital insurance – Part B—Physician, Outpatient hospital,

THE COMMONWEALTH FUND 1 Benefit Design: Access, Affordability, Risk Pooling Cathy Schoen Senior Vice President, Commonwealth Fund Benefits in Health Insurance.

THE COMMONWEALTH FUND New Evidence on Health Coverage For Aging Boomers: Findings from the Commonwealth Fund Survey of Older Adults Sara R. Collins, Ph.D.

Overview of the U.S. Health Care System American Medical Student Association.

Medicare Annual Enrollment Important Medicare Updates for 2015.

MEDICARE: PAST, PRESENT AND F UTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.

Deciphering Medicare Part D Susan Miller, Patient Education Douglas A. Magenheim, MD, MBA, FACP.

© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health? Get Educated, Get Enrolled An.

Medicare, Health Reform, and You. Don’t Worry! The benefits that Medicare guarantees will not change.

Medicare and the New Prescription Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser.

DataBrief: Did you know… DataBrief Series ● January 2012 ● No. 26 Dual Eligibles, Chronic Conditions, and Functional Impairment By Age Group In 2009, 29%

MEDICARE PRESCRIPTION DRUG BENEFIT Presented by Juliette Cubanski, Ph.D. Principal Policy Analyst Medicare Policy Project The Henry J. Kaiser Family Foundation.

1 State Perspectives on Medicare Part D: Lessons from Pharmacy Plus Programs Cindy Parks Thomas Donald Shepard Christine E. Bishop Daniel M. Gilden Brandeis.

© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?

Medicare in Minnesota 2012 Your Medicare: Making the Best Possible Decisions October 2011 Presented by Stephanie Minor Senior LinkAge Line® Program Consultant.

Patient Advocacy. Access, Affordability, and understanding treatment costs.

Jeffrey Levi, Ph.D. American Public Health Association Annual Meeting November 8, 2004 Options for enhancing quality and equity in the CARE Act: If not.

1 Medicare Prescription Drug Improvement and Modernization Act & Beneficiaries With Mental Illnesses Presentation to NAMI Convention June 19, 2005 Andrew.

Medicare Reforms LECTURE 15. Overview of 2003 Changes “The Medicare Prescription Drug, Improvement and Modernization Act of 2003” More commonly called.

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy.

Issues and Challenges Facing Medicare Mark L. Hayes.

Slide -1 Medicare Prescription Drug Benefit Denise S. Stanley, Pharm.D. Atlanta Regional Office Centers for Medicare & Medicaid Services March 17, 2006.

The Impact of Health Expenses on Older Women ’ s Financial Security Juliette Cubanski, Ph.D. The Henry J. Kaiser Family Foundation AcademyHealth 2007 Annual.

Medicare, Medicaid, and Health Care Reform Todd Gilmer, PhD Professor of Health Policy and Economics Department of Family and Preventive Medicine 1.

UllmanView Graph # 1 OVERVIEW Background and Basics of Cost-Sharing Designing Premiums Analysis of Impacts of Four States’ Premium Policies Implications.

Medicare and Patient Assistance Sean M. Dougherty Senior Director Medicare Strategy & Patient Assistance Programs Government, Public Policy And Managed.

Waiting for Medicare: Disparities in Health Care Experiences of Adults Age Compared to Adults 65 and Older Cathy Schoen Vice President, The Commonwealth.

Options to Extend Health Coverage in Delaware. Key Background Observations n Preponderance of uninsured are working families with incomes between 100%

Medicare Part D Symposium Thursday, September 1, 2005 Sacramento, CA Cathy Senderling Senior Legislative Advocate, CWDA.

The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.

THE COMMONWEALTH FUND Medicare Part D: What Are The Concerns? Stuart Guterman Director, Program on Medicare’s Future The Commonwealth Fund Association.

11/8/051 Medicare Prescription Drug Benefits Employee Workshop November 2005.

Return to Tutorials Tricia Neuman, Sc.D. Director, Medicare Policy Project Vice President, Kaiser Family Foundation For KaiserEDU June 2009 Medicare 101:

0 Beneficiary Choices in Medicare Part D and Plan Features in 2006 Supported by PhRMA September 13, 2006.

Medicaid “Reform” and Mental Health Leighton Ku Senior Fellow Presentation at NAMI Conference, June 2005

THE COMMONWEALTH FUND Karen Davis President, The Commonwealth Fund January 27, Health Savings Accounts.

Who Are the Dual Eligibles? May 17, 2006 Charles Milligan, JD, MPH Medicaid Commission Meeting.

DataBrief: Did you know… DataBrief Series ● February 2011 ● No. 11 Eligibility Pathways for Dual Eligibles In FY 2008, over 9 million Medicare beneficiaries.

Capital Hill Briefing January 24, 2011 How the ACA impacts the

Ian D. Spatz Merck & Co., Inc. January 14, 2004 Ian D. Spatz Merck & Co., Inc. January 14, 2004 Overview of the New Medicare Prescription Drug Law.

April 12, REVISED 1 Catamount Health Financial Facts Under the Senate Bill Kenneth E. Thorpe Emory University.

K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Figure 0 Medicare Modernization Act of 2003: Implications for Low-Income People and State.

The Potential Impact of Health Care Reform on California: Consumer Affordability Dylan H. Roby, Ph.D. Assistant Professor of.

"Helping Seniors Make Smart Decisions about their Drug Coverage Options" Hal Prink, FHFMA, Medicare Patient Advocate, Senior’s Voice for Healthcare Rights.

Presented by Stephanie Minor Statewide Senior LinkAge Line® Coordinator Minnesota Board on Aging Medicare in Minnesota 2011 Your Medicare After Health.

Figure 1 K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Dual Eligibles: The Basics Barbara Lyons, Ph.D. Director, Kaiser Commission on.

1 Cost Sharing for Low-Income Beneficiaries and Supplementing Part D Examples from Pharmacy Plus Medicaid Demonstration Programs Summit for State Health.

1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.

Medicaid Lecture 15A Medicaid Established in 1965 along with Medicare Medicaid is a federal and state program that helps low income and disabled individuals.

Rx Coverage, Use and Spending Among US Seniors: Where Did Things Stand on the Eve of Part D Implemention & How Can This Inform Us Now? Presented at: AcademyHealth.

Chapter 7: Medicare Part D Prescription Drug Coverage in Patients with Chronic Kidney Disease 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D.

Estimating the Cost of the Medicare Drug Benefit Philip Ellis Steve Lieberman Medicare Prescription Drug Congress February 27, 2004.

National Conference of State Legislatures National Medicaid Congress June 5, 2006 State Pharmaceutical Assistance Programs, Medicaid & Part D: 2006 State.

MEDICARE PART D July MEDICARE PART D: OVERVIEW Part D provides prescription drug coverage for Medicare beneficiaries. Prescription drug plans compete.

Avalere Health LLC | The intersection of business strategy and public policy The Impact of Enrollment in the Medicare Prescription Drug Benefit on Premiums.

AFFORDABLE CARE ACT CONSUMER IMPACT. WHAT’S CHANGING WITH THE ACA? What’s not changing with the ACA? Will have broad impact that affects some population.

State Responses to Medicare Part D Presented by: Kimberley Fox, Senior Policy Analyst, Institute for Health Policy Academy Health Annual Research Meeting.

Health Care Reform IT’S COMPLEX! Jeffery Thompson, MD MPH Chief Medical Officer Washington State Medicaid.

Overview of the Medicare Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser Family.

Cost Sharing Under Part D: Impact on Beneficiaries with the Standard Benefit Bruce Stuart, PhD Director, Peter Lamy Center on Drug Therapy and Aging.

MMA Implementation: Issues Facing States

Medicare Part D: What Are The Concerns?

Estimated Annual Premiums Under Different Scenarios, 2010

Medicare Rx Drug Benefit

CENTER FOR MEDICARE ADVOCACY, INC.

Presentation transcript:

Finance Team National Hispanic Medical Association Leadership Fellowship 2003 Jose Castro MD Elsa Escalera MD Inginia Genao MD Advisor: Charles Brecher PhD

The New Medicare Law: Implications for vulnerable population

Outline Overview Medicare prescription drug improvement and modernization act of 2003 Impact on the dual eligibles (Medicaid and Medicare) Recommendations Summary

Overview of the Medicare prescription drug improvement and modernization act of million beneficiaries of Medicare to new coverage of prescription drugs $ 410 billion (calculated by CBO) Voluntary benefit effective January 1, 2006 Annual premium in 2006 about $420—can vary by plan Annual $250 deductible indexed to drug spending Coverage gap (“donut hole”)—no coverage for spending between $2,250 and $5,100 Subsidies for low-income beneficiaries

Standard Drug Benefit Annual Deductible:$250$445 Coinsurance to Initial Limit:25% Initial Limit:$2,250$4,000 Out-of-Pocket Threshold:$3,600$6,400 Coverage Gap:$2,850$5,066 Coinsurance Above OOP: (greater of) $2/$5 or 5% $3/$8 or 5%

Dual Eligibles

Sources of Supplemental Coverage Among Non-Institutionalized Medicare Beneficiaries, 2000 Source: Analysis of 2000 MCBS by Bruce Stuart for The Commonwealth Fund. * Includes Medicaid, Veteran Affairs, and various other programs.

Dual eligibles: Who Are They? Medicaid fill gaps in Medicare > 7 million low- income seniors: enrolled in both Medicaid/Medicare. Must have income well bellow the poverty line and minimal assets to qualify for Medicaid, Dual eligibles are much poorer than other Medicare beneficiaries. They also tend to have far more extensive health care needs than other Medicare beneficiaries:

Dual Eligibles: How poor, how sick?  70% of dual eligibles have annual incomes < $ 10 K compared to 13 % of all other Medicare beneficiaries.  More than twice as likely to be in fair or poor health as other Medicare beneficiaries (52% versus 24%).  ~ 25% of dual eligibles are in long-term care facilities compared to 2% of other Medicare beneficiaries.  Dual eligibles are more than twice as likely to have Alzheimer’s (6% versus 3%), more likely to have diabetes (24% versus 17%) and to have suffered a stroke (14% versus 11%) than other Medicare beneficiaries.

New Medicare Law for Dual eligibles No deductible and no premium for enrolling in an average or low cost plan. Special assistance with cost-sharing obligations (no doughnut hole for dual eligibles). Will not pay for 100% once they exceed limit of $2,250. O income up to 100% of poverty: no more than $1/generic and $ 3/brand name drug in Majority will fall into this category. O dual eligibles with income >100% of poverty. $2/generic and $5/brand name drug in 2006.

Impacts on Dual Eligibles: Should the Fight Continue? Complex choices Navigating the system Variations from state to state Drug coverage restrictions under part D plan Array of drugs covered Cost-sharing

Implications of the New Medicare law for dual eligibles Likely to struggle with the new implications of the law, and perhaps, to be overwhelmed by the array of complex choices. They will be better o worse off with Part D will depend heavily on: the state in which they happen to reside, drugs covered under the plan in which they can afford to enroll, and their individual circumstances.

III Recommendations Focus in Hispanics: will have additional challenges. Measuring outcomes.

In 2002, almost 2 million Hispanics > 65 ys. Data gathering should be focused on this group to estimate the impact the new Medicare law. Data should be the best advocacy tool. One way to obtain reliable data is research.

Outcomes research Outcome research: measures outcomes. Set of analytic methods that produce information about the benefits, risks, and costs of health care services.

Measuring outcomes There are many potential measurements that can be incorporated in the study, but should be oriented to the particular characteristics of the study population, for example: MeasureExample Mortalitycardiovascular associated mortality Physiologyblood pressure Clinical eventsstroke Functional status SF-36, a 36 item health survey Experience with careConsumer Assessment of Health Plan

Summary Good benefits for many beneficiaries. May be a challenge for the most vulnerable, in particular Hispanics. Outcome research focus in this population and plan in advance.

Senate Majority Leader Bill Frist said, “This bill is an extraordinary day for seniors and indeed all Americans…The legislation we just passed is epochal…It modernizes Medicare to provide 21 st century care for our seniors.”

Senate Minority Leader Tom Daschle predicts that seniors would mobilize as they did 38 years ago for the original Medicare Bill once they learn how the bill works. “They [lobbyists] will do well. Our seniors will not, and that is why the fight will go on.”